Galera Therapeutics, Inc. - Common Stock (NQ:GRTX)

0.1450 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 3, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Galera Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

September 05, 2023

From Galera Therapeutics

Via GlobeNewswire

Expert Ratings for Galera Therapeutics ↗

August 29, 2023

Via Benzinga

Citigroup Maintains Neutral Rating for Galera Therapeutics: Here's What You Need To Know ↗

August 29, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023 ↗

August 16, 2023

Via Benzinga

Analyst Ratings for Galera Therapeutics ↗

March 22, 2023

Via Benzinga

Where Galera Therapeutics Stands With Analysts ↗

March 22, 2023

Via Benzinga

Galera Reports Second Quarter 2023 Financial Results and Recent Corporate Updates

August 14, 2023

From Galera Therapeutics

Via GlobeNewswire

Gold Edges Lower; Alibaba Posts Upbeat Results ↗

August 10, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Thursday. The Dow traded up 0.44% to 35,277.94 while the NASDAQ rose 0.29% to 13,761.56. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 10, 2023

Via Benzinga

Crude Oil Down 1%; Disney Profit Tops Expectations ↗

August 10, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 0.78% to 35,396.50 while the NASDAQ rose 0.84% to 13,837.91. The...

Via Benzinga

Topics Stocks

Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

August 10, 2023

Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.

Via Benzinga

Disney Explores Strategic Shift Away from Traditional TV, FTX Management & Creditors Clash, Alibaba's Q1 Earnings: Today's Top Stories ↗

August 10, 2023

Financial Times

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023 ↗

August 10, 2023

Via Benzinga

Dow Jumps Over 300 Points; US Inflation Rate Rises To 3.2% ↗

August 10, 2023

U.S. stocks traded higher this morning, following the release of inflation data on Thursday. Following the market opening Thursday, the Dow traded up 0.95% to 35,456.19 while the NASDAQ rose 1.03% to...

Via Benzinga

Topics Economy Stocks

What Is Going on With Applied UV (AUVI) Stock Today? ↗

August 10, 2023

Applied UV (AUVI) stock is on the move Thursday as investors react to the disinfectant company getting $4 million in orders.

Via InvestorPlace

Why Is Galera Therapeutics Stock Sinking Today? ↗

August 10, 2023

The FDA issued a Complete Response Letter (CRL) to Galera Therapeutics Inc's (NASDAQ: GRTX) New Drug Application (NDA) for avasopasem manganese (avasopasem) for radiotherapy-induced severe oral...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 10, 2023

Via Benzinga

Why Is Amyris (AMRS) Stock Down 67% Today? ↗

August 10, 2023

Amyris (AMRS) stock is falling on Thursday after the company filed for Chapter 11 bankruptcy protection to facilitate a restructuring.

Via InvestorPlace

Topics Bankruptcy

Why Is Galera Therapeutics (GRTX) Stock Down 83% Today? ↗

August 10, 2023

Galera Therapeutics (GRTX) stock is falling hard on Thursday following a drug rejection by the FDA and plans to cut its workforce!

Via InvestorPlace

Why AppLovin Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket ↗

August 10, 2023

Gainers PHAXIAM Therapeutics S.A. (NASDAQ: PHXM) shares surged 46.7% to $0.64 in pre-market trading after gaining 6% on Wednesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 10, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders should watch on Thursday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 09, 2023

Via Benzinga

Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese

August 09, 2023

From Galera Therapeutics

Via GlobeNewswire

Why Hims & Hers Health Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket ↗

August 08, 2023

Gainers Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) shares surged 83.5% to $0.1648 in pre-market trading after falling over 25% on Monday. The company recently announced its plans to reduce the...

Via Benzinga

Galera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual Meeting

June 05, 2023

From Galera Therapeutics

Via GlobeNewswire

Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer

May 18, 2023

Rucosopasem in clinical development to augment the anti-cancer efficacy of stereotactic body radiation therapy

From Galera Therapeutics

Via GlobeNewswire

Galera Reports First Quarter 2023 Financial Results and Recent Corporate Updates

May 11, 2023

From Galera Therapeutics

Via GlobeNewswire

Galera Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 04, 2023

From Galera Therapeutics

Via GlobeNewswire

Galera Expands Commercial Leadership Team

May 01, 2023

From Galera Therapeutics

Via GlobeNewswire

Galera to Present One-Year Reductions in Cisplatin-Related Chronic Kidney Disease Data from ROMAN Trial at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

April 26, 2023

From Galera Therapeutics

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.